Methodologies and outcomes of clinical trials of erenumab in episodic... | Download Scientific Diagram
Safety and tolerability of erenumab in individuals with episodic or chronic migraine across age groups: a pooled analysis of placebo-controlled trials | The Journal of Headache and Pain | Full Text
Optimal treatment strategy of fremanezumab in migraine prevention: a systematic review with network meta-analysis of randomized clinical trials | Scientific Reports
![PDF] Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2b5d2470ef97a1399bd34d281f9f37ddf42e79f0/4-Figure1-1.png "PDF] Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study | Semantic Scholar")
PDF] Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study | Semantic Scholar
![PDF] ARISE: A Phase 3 randomized trial of erenumab for episodic migraine | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/57b8c7a7cd9246b7072730224457f3a70d5b4e82/5-Table2-1.png "PDF] ARISE: A Phase 3 randomized trial of erenumab for episodic migraine | Semantic Scholar")
PDF] ARISE: A Phase 3 randomized trial of erenumab for episodic migraine | Semantic Scholar
Study design of the episodic migraine trial (a) and the chronic... | Download Scientific Diagram
Migraine prevention with erenumab | TCRM
Frontiers | Erenumab for Migraine Prevention in a 1-Year Compassionate Use Program: Efficacy, Tolerability, and Differences Between Clinical Phenotypes
Long-term Efficacy and Safety of Erenumab | Neurology
Novartis announces positive results from a Phase IV study showing superior tolerability and efficacy of Aimovig® (erenumab) compared with topiramate in migraine prevention | Novartis
A Controlled Trial of Erenumab for Episodic Migraine | NEJM
Aimovig (erenumab) for the Treatment of Episodic Migraine
Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study - The Lancet
PDF) A Controlled Trial of Erenumab for Episodic Migraine
Novartis data confirm long-term efficacy and safety of Aimovig® for majority of patients with episodic migraine | Novartis
Early onset of efficacy with erenumab in patients with episodic and chronic migraine | The Journal of Headache and Pain | Full Text
ARISE: A Phase 3 randomized trial of erenumab for episodic migraine - David W Dodick, Messoud Ashina, Jan Lewis Brandes, David Kudrow, Michel Lanteri-Minet, Vera Osipova, Kerry Palmer, Hernan Picard, Daniel D
A Controlled Trial of Erenumab for Episodic Migraine | NEJM
Erenumab: First-in-Class Approved for Migraine Prevention
Aimovig® (erenumab-aooe) for the Preventive Treatment of Migraine in Adults
Erenumab for the Prevention of Migraine, Including the Rationale, Findings and Clinical Implications of the LIBERTY Study - touchNEUROLOGY
A Controlled Trial of Erenumab for Episodic Migraine | NEJM
Reversion from chronic migraine to episodic migraine following treatment with erenumab: Results of a post-hoc analysis of a randomized, 12-week, double-blind study and a 52-week, open-label extension - Richard B Lipton, Stewart
